Ethnicity | |||||
---|---|---|---|---|---|
Comorbidities | Comorbidity | Other | Māori | Pacific | Asian |
HR (95%CI) a | HR (95%CI) b | HR (95%CI) c | HR (95%CI) c | HR (95%CI) c | |
No comorbidity adjustment/inclusion | 1.00 | 1.56 (1.19-2.05) | 1.95 (1.21-3.13) | 0.72 (0.41-1.27) | |
Elixhauser as continuous variable | 1.25 (1.11-1.40) | 1.00 | 1.55 (1.19-2.04) | 1.92 (1.20-3.09) | 0.72 (0.41-1.26) |
Individual comorbities | |||||
Congestive heart failure | 2.35 (1.22-4.52) | 1.00 | 1.57 (1.20-2.06) | 1.98 (1.23-3.17) | 0.72 (0.41-1.27) |
Valvular disease | 2.84 (0.70-11.61) | 1.00 | 1.56 (1.19-2.04) | 1.96 (1.22-3.14) | 0.72 (0.41-1.27) |
Hypertension, complicated | 1.74 (0.24-12.72) | 1.00 | 1.57 (1.19-2.06) | 1.95 (1.22-3.13) | 0.72 (0.41-1.27) |
Chronic pulmonary disease | 1.62 (0.95-2.77) | 1.00 | 1.55 (1.18-2.03) | 1.95 (1.22-3.13) | 0.67 (0.38-1.19) |
Diabetes, complicated | 10.46 (3.01-36.37) | 1.00 | 1.55 (1.18-2.04) | 1.70 (1.03-2.80) | 0.71 (0.40-1.25) |
Renal failure | 4.27 (2.08-8.76) | 1.00 | 1.58 (1.20-2.07) | 1.70 (1.04-2.77) | 0.72 (0.41-1.27) |
Liver disease | 2.43 (0.76-7.78) | 1.00 | 1.55 (1.18-2.03) | 1.92 (1.20-3.09) | 0.72 (0.41-1.26) |
Coagulopathy | 2.78 (0.68-11.43) | 1.00 | 1.55 (1.18-2.03) | 1.91 (1.19-3.07) | 0.72 (0.41-1.27) |
Obesity | 3.52 (1.55-7.98) | 1.00 | 1.55 (1.18-2.04) | 1.90 (1.18-3.05) | 0.72 (0.41-1.27) |
Fluid and electrolyte disorders | 4.03 (2.01-8.08) | 1.00 | 1.51 (1.15-1.98) | 1.97 (1.23-3.16) | 0.69 (0.39-1.21) |
Blood loss anaemia | 2.44 (1.48-4.00) | 1.00 | 1.53 (1.17-2.01) | 1.98 (1.23-3.17) | 0.71 (0.40-1.26) |
Drug abuse | 3.28 (0.45-23.76) | 1.00 | 1.56 (1.19-2.04) | 1.95 (1.22-3.13) | 0.72 (0.41-1.27) |
Multivariate - all 12 of the above | 1.00 | 1.44 (1.09-1.89) | 1.62 (0.98-2.68) | 0.63 (0.35-1.13) |